Key Benefits:
Law 14/2011, of June 1, of Science, Technology and Innovation, classifies various organisms and among them the Carlos III Health Institute as a public research body.
Article 61 of Law 50/1998, of 30 December, of Fiscal, Administrative and Social Order Measures, provides that public research bodies shall adopt the configuration of an autonomous body established in the Article 43 (1) (a) of Law 6/1997, of 14 April, of the Organization and the Functioning of the General Administration of the State, with certain peculiarities in the field of personnel, economic resources, budgetary, financial and financial accounting, intervention and financial control.
By Royal Decree 345/2012 of 10 February, which develops the basic organic structure of the Ministry of Economy and Competitiveness, the Carlos III Health Institute is attached to this department, through the Secretary of State for Research, Development and Innovation.
The Carlos III Health Institute is providing certain public services related to its functions through the national centers that are part of its organic structure.
The Carlos III Health Institute, in the provision of services, the supply of goods and the performance of activities, in accordance with the rules invoked, may establish public prices as a financial consideration for such services. activities in the terms laid down in Law 8/1989 of 13 April of Fees and Public Prices, since the services provided by this body present the characteristics required by that Law for the financial compensation to be paid they satisfy themselves for the consideration of public prices at the time at the same time, the two criteria which make it up, that is, pecuniary contracts which are satisfied by the supply of goods, services or the performance of activities carried out underrule of law, where these are not are mandatory to be received by the administered authorities, and that such deliveries, benefits or activities are likely to be provided or carried out effectively by the private sector, as there is no reserve in favour of the public sector in accordance with the rules in force.
This activity was regulated so far in the Resolution of 12 November 2011, by the Carlos III Health Institute (BOE No. 290, of 2 December) laying down the public prices corresponding to the carrying out of works of a scientific nature or of technical advice and other activities of the body.
This resolution modifies public prices for the provision of services and the performance of activities with a dual purpose:
First, it is necessary to update the catalogue of services provided, since during the period since its publication certain demands for services that were not covered by the regulation have been created. in force, while the demand for other benefits that were regulated has been disappearing.
Second, it is necessary to update the amounts of the prices in force for the purpose of adjusting them to cover the costs of the services provided, in compliance with the provisions of Article 25 of Law 8/1989, of 13 April, for Public Fees and Prices.
In view of the above and in view of the diversity of changes to be made, it has been considered appropriate to bring together the changes required by the subject matter in a new resolution allowing for greater clarity and ease of application, unifying criteria and taking into account the characteristics of the services offered from the body.
In its virtue, and as provided for in Article 26.1.b) of Law 8/1989, of 13 April, and in accordance with the jurisdiction conferred by it by Article 13.2 of Order ECC/1695/2012 of 27 July 2012, competencies, this Address resolves:
First.
Set the amount of public prices to be collected by the public research body Carlos III Health Institute for the provision of services or for the performance of activities, included in the Annex, that are carried out under public law by the National Center for Microbiology.
Second.
Access to the standard application for the performance of the services listed in the Annex will be made through the website https://cnm-laboratorios.isciii.es.
Users must be identified by authorization granted by the National Center for Microbiology, consisting of a personal key that will be provided upon request.
Third.
The amount of the prices set out in the Annex to this resolution may be updated, with effect from 1 January of each year, in whole or in part. In order to carry out this update, account will be taken of the evolution of the Consumer Price Index published by the National Statistics Institute in the period since the last update, as well as the evolution of the prices of the sector in which the activity is developed.
Fourth.
Regardless of the prices listed in the Annex, services of a special nature or of a special strategic interest shall be provided at no cost, in the following cases:
Study of outbreaks or cases of any infectious etiology that are of special alarm or concern from the point of view of health, provided that they are requested, in a reasoned manner, through the state health authorities or of the Autonomous Communities.
National, European or international surveillance programmes in which infectious agents are required to be confirmed and/or characterised in a reference laboratory. The pathogens included in these programs will be identified in the telematics application of the services portfolio of the National Center for Microbiology of the Health Institute Carlos III.
Fifth.
The payment of the public prices will be made by the income of its amount in the account that the agency has authorized to the effect in the Banco de España with IBAN ES45 9000.0001.20.0200009118.
Single repeal provision.
The Resolution of 12 November 2011, of the Carlos III Health Institute, which establishes public prices for the performance of scientific or technical advice and technical advice, is hereby repealed. other activities of the body.
Single end disposition.
This Resolution shall enter into force within thirty working days after its publication in the "Official State Gazette".
Madrid, March 22, 2013. -Director of the Health Institute Carlos III, Antonio Luis Andreu Periz
ANNEX
| agent | Pathogen (analytic method) | Price without VAT |
|||
|---|---|---|---|---|---|
| Bacteria. | Acinetobacter (molecular characterization) | 78.75 | |||
| Bacteria. | IgM/IgG Anaplasma (IFI) |
46.50 | |||
|
Bacteria. | Anaplasm/Ehrlichia (PCR-hybridization) | 38.00 | |||
| Bacillus anthracis (characterization) | 207.50 | ||||
| Bacteria. | Bacillus anthracis (PCR) | 38.00 | |||
|
Bacteria. | Gram negative bacteria (molecular characterization) |
78.75 | |||
|
Bacteria. | Bartonella (characterization) | 120,50 | |||
| Bacteria. | 38.00 | ||||
|
Bacteria. | Bartonella IgM/IgG (IFI) | 34.25 | |||
|
Bacteria. | Bordetella pertussis Ac (ELISA) | 21.75 | |||
|
| 98.20 | ||||
| Bordetella pertussis (PCR) | 42.50 | ||||
|
Bacteria. | Borrelia (PCR-hybridization) | 38.00 | |||
| Borrelia burgdorferi IgG + IgM (ELISA/WB) | 30,50 | ||||
|
Bacteria. | Brachyspira spp. (PCR-hybridization) | 38.00 | |||
|
Bacteria. | Brucella sp. (PCR-hybridization) | 38.00 | |||
| Burkholderia pseudomallei (IFI) | 17.50 |
||||
| Bacteria. |
38.00 | ||||
| Bacteria. | Campylobacter (characterization) | 71.50 | |||
| Bacteria. | Chlamydia (FC) | 10.30 | |||
|
| |||||
| Bacteria. | Chlamydia IgM (IFI) | 5.00 | |||
|
Bacteria. | Chlamydia trachomatis Ag (IFD) | 15.75 | |||
|
| 182.00 | ||||
| Bacteria. |
182.00 | 182.00 | 9.50 |
| |
| Bacteria. | Corynebacterium diphteriae IgG (ELISA) | 9.50 | |||
|
Corynebacterium sp. characterization) | 85.00 | ||||
|
Coxiella burnetti (FC) | 10.30 | ||||
|
Bacteria. |
Coxiella burnetti (PCR-hybridization) | 38.00 | |||
|
Bacteria. | Coxiella burnetti, Acute Phase (IFI) | 10.50 | |||
|
Coxiella burnetti, chronic phase (IFI) | 12.75 | ||||
|
Bacteria. | Enterobacter (molecular characterization) | 78.75 | |||
| Escherichia coli (characterization) | 94.50 | ||||
|
Bacteria. | Negative coagulase (molecular characterization) | 72.75 | |||
|
Bacteria. |
38.00 | ||||
| Bacteria. |
| ||||
|
5.00 |
5.00 | 5.00 Table_table_izq"> Haemophilus sp. (characterization) | 76.50 | ||
|
78,75 | 78.75 | ||||
|
102.50 | |||||
| 102.50 | |||||
| The_table_table_izq"> Bacteria. | Legionella (characterization) | 96,50 | |||
| Legionella pneumophila SG1 Ac (IFI) | 7.00 | ||||
|
Bacteria. | Legionella pneumophila SG1 IgM (IFI) | ||||
|
Bacteria. | Leptospira IgM (ELISA) |
31.00 | |||
|
Bacteria. | Leptospira sp. (PCR-hybridization) | 38.00 | |||
| Bacteria. | Listeria sp. (characterization) | 74.00 | |||
|
| Bacterial Meningitis (PCR-multiplex) | 142.00 | |||
|
Bacteria. | Mycobacterium tuberculosis (characterization) |
63.00 | |||
|
Bacteria. | Mycobacterium non-tuberculosis (characterization) | 63.00 | |||
|
| 7.75 |
| |||
| Bacteria. | Mycoplasma pneumoniae IgM (ELISA) | 7.75 | |||
| Bacteria. | Neisseria gonorrhoeae (characterization) |
80.00 | |||
|
Neisseria meningitidis (bactericidal activity) | 100.50 | ||||
| Neisseria meningitidis (characterization) | 154.00 | ||||
|
Neisseria sp. identification) |
| 17,00 | |||
| Pseudomonas aeruginosa (molecular characterization) | 109.00 | ||||
| Antibiotic Resistance (characterization) | 93.50 | ||||
|
| |||||
|
7.00 | Rickettsia conorii IgM (IFI) | ||||
|
Bacteria. | Rickettsia sp. (PCR-hybridization) | 38.00 | |||
|
| 81.25 | ||||
| Bacteria. |
(serotyped) | 66.75 | |||
|
Bacteria. | Serratia (molecular characterization) | 78.75 | |||
| Shigella (characterization) | 83.75 | ||||
|
Bacteria. |
103.00 | ||||
| Bacteria. | 103.00 | 103.00 |
Table_table_izq"> Staphylococcus aureus; PVL, SST, and TSST (PCR) toxins | 60.50 | |
|
Streptococcus pneumoniae (characterization) | 57.00 | ||||
|
Streptococcus pyogenes (characterization) | 109.00 | ||||
|
Bacteria. | Bacterial Taxonomy (characterization) | 121.30 | |||
| Treponema pallidum (FTA-lcr) | 11.20 |
||||
| Bacteria. | Treponema pallidum (PCR-hybridization) | 38.00 | |||
| Bacteria. | Treponema pallidum (RPR/TPHA/FTA) | 31.50 | |||
|
Bacteria. | Treponema pallidum Ac (TPHA-confirmatory) |
7.90 | |||
|
Bacteria. | Treponema pallidum IgM (FTA) | 16.75 | |||
| Bacteria. | Trotheryma whipplei (electron microscopy: ultramicrotomy) | 93.00 | |||
| Bacteria. |
38.00 |
| |||
| Bacteria. | Vibrio (characterization) | 77.50 | |||
|
83.75 | |||||
| 83.75 |
Bacteria. | Yersinia pestis (PCR-hybridization) | 38.00 | ||
|
Hongos. | Aspergillus spp. (PCR-multiplex) | 182.30 | |||
|
Hongos. | Candida albicans (PCR) | 157.75 | |||
| Candida spp. (PCR) | 182.00 | ||||
|
Hongos. | Histoplasma capsulatum (PCR) | 157.75 | |||
|
Hongos. | Endemic Hongos (immunodiffusion) | 101.00 | |||
|
Fungi. | Filamentary Fungi (identification and sensitivity) | 176.00 | |||
|
Hongos. | Filamentous Honours (identification) | 109.00 | |||
|
Hongos. | Itraconazole (quantification) | 115,50 | |||
|
Hongos. |
| 138.75 | |||
|
Hongos. |
(identification) | 96.50 | |||
|
Hongos. | Panfungium (PCR) | 144.50 | |||
|
Hongos. |
| 157.75 | |||
|
(quantification) | 115.50 | ||||
|
Hongos. | Scedosporium apiospermum (PCR) | 157.75 | |||
|
Hongos. |
Scedosporium prolific (PCR) | 157.75 | |||
|
Hongos. | Voriconazole (quantification) | 115.50 | |||
|
Hongos. | Zigomycetes (multiplex PCR) | 182,25 | |||
|
parasites. |
|
57.75 | |||
| Parasites. | Anisakis IgE (ELISA; rAni s1/s7) | 35.00 | |||
| parasites. | arthropods (Identification) | 156.00 | |||
| . |
|
146.00 | |||
|
Babesia sp. |
146.00 |
(characterization) | 151.50 | ||
|
parasites. | cryptosporidium (Characterization) |
102.00 | |||
|
parasites. | Cryptosporidium (PCR) | 51.50 | |||
|
parasites. | Echinococcus granulosus IgG, IgG1, IgG4 (ELISA) | ||||
| parasites. | Echinococcus granulosus/E. | 68.00 | |||
| parasites. | entamoeba histolytica IgG (ELISA) |
19.50 | |||
|
parasites. | entamoeba histolytica/E. disparate (actual PCR-time) | 57.50 | |||
| parasites. | Ac hepatic fasciola (ELISA-MM3) |
||||
|
parasites. | Filarias (PCR) | 53.50 | |||
| parasites. | Giardia (characterization) | 102.00 | |||
| parasites. | Giardia (actual PCR-time) | 54.00 | |||
| Giardia Ag (ELISA) | 31.50 | ||||
| Parasites. | Giardia and Cryptosporidium Ag (IFD) | 45.00 | |||
|
parasites. | Leishmania (molecular characterization) | 83.50 | |||
|
parasites. | Leishmania (culture) | 20.60 | |||
| parasites. | Leishmania (ICT rK39) | 15.75 | |||
|
parasites. | Leishmania (PCR-neted) | 38.00 | |||
|
parasites. | Leishmania (xenodiagnostic) | 287.50 |
|||
|
parasites. | Leishmania in arthropod (isolation and characterization) | 210.00 | |||
| parasites. | Leishmania in arthropod (PCR) | 134.00 | |||
|
parasites. | Leishmania IgG (IFI) | 20.00 | |||
|
parasites. |
57.00 | ||||
|
parasites. | Onchocerca IgG, IgG1, IgG2, IgG3, IgG4 (ELISA) | 20,50 | |||
|
parasites. | Intestinal Parasites (optical microscopy) |
57.00 | |||
|
| Plasmodium (PCR-quantitative tracking) | 42.50 | |||
|
| plasmodium (pCR-multiplex) | 53.25 | |||
| parasites. |
Plasmodium falciparum (resistors) | 418.50 | |||
|
parasites. | Plasmodium IgG (IFI) | ||||
| parasites. | Plasmodium spp. (ELISA) | ||||
|
parasites. | Schistosoma IgG (ELISA) | 19.50 | |||
| parasites. | Strongyloides IgG (ELISA) | 15.75 |
|||
|
parasites. | Taenia saginata/T. solium (PCR) | 52.50 | |||
|
parasites. | Taenia solium (PCR HDP2-seminested) | 64.00 | |||
|
parasites. | Taenia solium Ag (ELISA) | ||||
| parasites. | Taenia solium IgG (ELISA) | 19.50 | |||
|
parasites. | Taenia solium IgG (ELISA-FV) | 14,50 | |||
|
parasites. | IgG Toxocara (ELISA) | 19.50 | |||
| parasites. | Toxoplasma gondii (characterization) | 102.00 | |||
| parasites. | gondii Toxoplasma (PCR-nested and PCRc) |
57.50 | |||
|
parasites. | IgG gondii Toxoplasma (ELFA) | 20.50 | |||
|
parasites. | Toxoplasma gondii IgG (ELISA; avidity) | 30,30 | |||
| parasites. | Toxoplasma gondii IgM (ELFA) | 22.00 | |||
|
parasites. | Trichinella (chlorhydropepsica digestion) |
59.50 | |||
|
| Tricinella (WB: US5 and US9) | 59.50 | |||
| parasites. | Trichinella IgG (IFI) | ||||
|
parasites. | Trichinella spp (PCR-multiplex) | 52.00 | |||
|
42.75 | 42.75 | ||||
| 42.75 | |||||
| Vermin. | trypanosoma brucei Ac (agglutination) | 9.70 | |||
| parasites. | Trypanosoma cruzi (molecular characterization) | 83.50 | |||
| parasites. | trypanosoma cruzi (culture) | 20.50 |
|||
| parasites. | trypanosoma cruzi (PCR) | 32.00 | |||
|
| Trypanosoma cruzi IgG (recombinant ELISA) |
13.35 | |||
|
parasites. | trypanosoma cruzi IgG (ELISA) | 13.35 | |||
| parasites. | Trypanosoma cruzi IgG (IFI) | 20.00 |
|||
|
parasites. | Wuchereria/Brugia IgG, IgG1, IgG2, IgG3, IgG4 (ELISA) | 20,50 | |||
|
Prions. | Prion gene PRPN (PCR-sequencing) | 220.75 | |||
| Prion protein 14-3-3 (WB) | 154.00 |
||||
|
Virus. | Adenovirus (characterization) | 151.50 | |||
|
Virus. | Adenovirus (FC) | 10.30 | |||
| Adenovirus (actual PCR-Time) | 117.00 |
||||
|
Virus. | enteric adenovirus (PCR) |
||||
|
. | Alphavirus (PCR) | 101.20 |
|||
| Virus. | Arenavirus (PCR) | 113.40 | |||
|
. | Astrovirus (characterization) | 89.00 | |||
| Virus. | Astrovirus (RT-PCR) | 57.50 | |||
| Virus. | Bunyavirus California Encefalitis group (PCR) | 101.25 | |||
| Virus. | IgG Citomegalovirus (ELISA) | 27.75 | |||
| IgG Citomegalovirus (ELISA; avidity) | 21.75 | ||||
|
Virus. | Citomegalovirus IgM (ELISA) | 27.75 | |||
| Virus. | Citomegalovirus and Virus Epstein-Barr (viral load, PCR-real time) | 41.00 | |||
|
. | Entero-Herpesvirus neurotropes (RT-PCR-real time) | 28.00 | |||
|
. | Enterovirus (isolation) | 63.75 | |||
|
Virus. | 59.50 | ||||
| Enterovirus (RT-PCR; region) 5NCR) | |||||
|
. | Enterovirus (serotyped) | 42.50 | |||
|
| 101.25 | ||||
| Virus. | Hantavirus (PCR) | 101.25 | Hantavirus (PCR) |
101.25 | |
|
. | Hantavirus IgG (ELISA) | 26.00 |
|||
|
Virus. | Hantavirus IgM (ELISA) | 35.00 | |||
|
. | HTLV IgG (ELISA) | 36.00 | |||
| Virus. | HTLV IgG (immunoblot) | 163.75 | |||
| Virus. | HTLV-I (PCR) | 85,50 | |||
| Virus. | HTLV-II (PCR) | 85.50 | |||
|
Virus. | Lyssavirus (characterization) | 75.80 | |||
|
. |
Lyssavirus (PCR) | 23.00 | |||
|
Virus. | Norovirus (characterization) | 89.00 | |||
|
Virus. | Norovirus (RT-PCR) | 57.50 | |||
|
. | Orthopoxvirus (real-time PCR-body) | 1114,50 | |||
|
Virus. | High Risk DNA Papillomavirus (Hybrid Capture) | 66.75 | |||
| Virus. | cutaneous Papillomavirus (genotyping) | 142.00 | |||
| Virus. | cutaneous Papillomavirus (PCR) | 85.00 | |||
| Virus. | Mucosal-year-genital Papillomavirus (genotyping-sequencing) | 142.00 | |||
| Virus. | Mucosal-year-genital Papillomavirus (PCR) | 85.00 | |||
|
Virus. | Papillomavirus mucosal-year-genital (PCR-hybridization) | 176.50 | |||
|
. | Human Parechovirus (PCR-Time actual) | 53.40 | |||
|
. | Parvovirus-B19 IgG (ELISA) | 18,00 | |||
|
| 21.75 | ||||
| Virus. | Phlebovirus (PCR) |
| 101.25 | ||
|
Virus. | Ac Poliovirus (neutralization) | 25,00 | |||
|
| 89.00 | ||||
| Rotavirus (RT-PCR) | 89.00 | 89.00 | 57.50 | ||
|
Virus. | HIV IgG (immunoblot) | 123.75 | |||
|
Virus. | HIV IgG-Ag (ELISA) | 34.00 | |||
|
. | HIV-1 (genotyped) | 265.50 | |||
| HIV-1 Proviral DNA (PCR) | 128.50 | ||||
|
Virus. | HIV-1, antiretroviral resistors (sequencing) | 237.00 | |||
|
Virus. | HIV-1, tropism, and subtype V3 (sequencing) |
105.50 | |||
|
. | HIV-1 Proviral DNA (PCR) | 118.25 | |||
|
Virus. | Virus Chikungunya (actual PCR-time) | 106.00 | |||
|
Virus. | Chikungunya Ac Virus (neutralization) | 206.00 | |||
|
Virus. | Chikungunya IgG (IFI) Virus | 19.00 | |||
| Virus Chikungunya IgM (IFI) | 22.75 | ||||
|
. | Linfocitary Coriomenyngitis (PCR) Virus |
89.00 | |||
|
. | Ig (IFI) Lymphocytic Cell (IFI) Virus | 10.50 | |||
| Icro_table_izq"> Virus Coriomenyngitis Linfocitaria IgM (IFI) | 14.20 | ||||
|
. | Virus Crimea-Congo (actual PCR-time) | 106.00 | |||
|
Virus. | Dengue Virus (actual PCR-time) |
106.00 | |||
|
Virus. | Virus Dengue Ag-S1 (ELISA) | 88.00 | |||
|
. | Virus Dengue IgG (ELISA) | 12.50 | |||
|
. | Virus Dengue IgM (ELISA) | 24.75 | |||
| The_table_table_izq"> Virus Ebola and Marburg (actual PCR-time) | 113.40 | ||||
| Virus. | Virus IgG-transmitted encephalitis (ELISA) | 41.00 | |||
|
. | Encefalitis Virus transmitted by IgM ticks (ELISA) | 41.00 | |||
|
Virus Epstein-Barr EA IgG (IFI) | 17.25 | ||||
| Virus. |
Epstein-Barr EBNA Ac (ACIF) | 8.00 | |||
| Virus. | Virus Epstein-Barr VCA IgG (IFI) | 19.00 | |||
| Virus Epstein-Barr VCA IgM (IFI) | |||||
| Virus. |
Exempt Virus (PCR-multiplex) | 21.80 | |||
|
. | Virus Yellow Fever (actual PCR-time) | 106.00 | |||
| Virus. | IgG Yellow Fever (IFI) Virus | 19.00 | |||
| Virus. | Virus Yellow Fever IgM (IFI) | 22.75 | |||
|
. |
Virus Yellow Fever (PCR-real) virus | 106.00 |
|||
| Virus. | Flu Virus (characterization) | 89.75 | |||
|
Virus Influenza A (FC) | 10.25 | ||||
| Virus. | Zant_table_izq"> Virus Influenza A, Ac (IHA) | 35.75 | |||
|
Virus Influenza A, B, C (PCR-multiplex) | 39.50 | ||||
| Virus. | Flu Virus B (FC) | 10.25 | |||
|
. | Flu Virus B, Ac (IHA) | 35.75 | |||
| Virus. | Flu virus, anti-viral resistance (sequencing) | 61.25 | |||
| Virus. | Virus Hepatitis A (confirmation) | 45.50 | |||
|
. |
Hepatitis A Virus (RT-PCR) | 32.75 | |||
| Virus. | Hepatitis B Virus (viral load, bDNA) | 58.20 | |||
| Virus. | Hepatitis B Virus (viral load, PCR-real time) | 67.30 | |||
| Virus. | Virus Hepatitis B (commit) | 114.00 | |||
| Virus. | Virus Hepatitis B (quantification Ag surface, ELISA) | 27.30 | |||
| Virus Hepatitis B (genotyped) | 37.00 |
||||
|
Virus. | Hepatitis B Virus (resistors antivirals) | 37.00 | |||
|
. | Virus Hepatitis B (region S variant) | 37.00 | |||
| Virus Hepatitis B (preC and X regions variants) | 49.75 | ||||
| Virus. | Virus Hepatitis B, phylogeny (whole sequencing) | 417.00 | |||
|
. | Hepatitis C Virus (confirmation) | 174.00 | |||
|
Virus. | Hepatitis C Virus (quantification Ag core, ELISA) |
39.50 | |||
| Virus. |
214.75 | ||||
| . | Virus. | Virus. | Virus. | Virus. Hepatitis C (genotyping) | 154.60 |
|
. | Hepatitis C Virus (RT-PCR) | 32.75 | |||
|
| 54.00 | ||||
| Virus Hepatitis C IgG (ELISA; avidity) | 23.00 | ||||
|
Virus. | Virus Hepatitis C; IL28B (actual PCR-time) |
97.00 | |||
|
Virus. | Hepatitis C Virus; ITPA (actual PCR-time) | 97.00 | |||
|
Virus. | Virus Hepatitis D (viral load, PCR-real-time) | 67.30 | |||
| Virus. | Virus Hepatitis D (confirmation) | 49.75 | |||
|
Virus Hepatitis D (RT-PCR) | 32.75 | ||||
| Virus. |
Hepatitis E Virus (confirmation) | 100.75 | |||
|
. | Hepatitis Virus E (genotyping) | 56.00 | |||
|
Virus. | Hepatitis E Virus (RT-PCR) | 32.75 | |||
|
. |
Virus Hepatitis E IgM (immunoblot) | ||||
|
. | Virus Herpes Human 8 IgG (IFI) | 61.50 | |||
| Virus. | Herpes Lymphotropes Virus (PCR-real time multiplex) | 35.00 | |||
|
Virus Herpes Simple (FC) | 10.30 | ||||
| Virus. |
IgG Herpes Simplex Virus (ELISA) | 15.50 | |||
| Virus. | Simple IgM Herpes Virus (ELISA) | 19.25 | |||
| Virus. | Herpes Simple Type-1 and Type-2 IgG (immunoblot) | 37.25 | |||
| Virus. | Identification Virus (electron microscopy: negative staining) | 29.00 | |||
| Virus identification (electron microscopy: ultramicroomy) | 93.00 | ||||
| Virus. | Virus JC and BK (multiplex real time PCR-PCR-PCR-PCR-body) | 36.40 | |||
|
Virus. | Virus O ' Nyong Nyong Ac (neutralization) | 206.00 | |||
|
Virus. | Parotiditis Virus (genotyping) |
42.50 | |||
|
. | Parotiditis Virus (PCR) | 21.80 | |||
| Virus. | IgG Parotiditis Virus (ELISA) | 17.50 | |||
|
. | IgM Parotiditis Virus (ELISA) | 19.25 | |||
| Virus. | Virus Rabia Ag (IFI) | 43.00 | |||
| Virus. | Virus Rabia IgG (ELISA) |
Virus | |||
| Virus. | Syncytial Respiratory Virus (FC) | 10.30 |
|||
| Virus. | Respiratory Virus (PCR-multiplex) | 44.25 | |||
| Virus. | Respiratory Bronchiolitis Virus (PCR-multiplex) | 42.00 | |||
|
Virus. | Rubeola Virus (genotyped) | 42.50 | |||
| Virus. | Virus Rubeola Ac (ELISA; avidity) | 21.60 |
|||
|
Virus. | Virus Rubella IgG (ELISA) | 27.75 | |||
|
. | Virus Rubella IgM (ELISA) | 27.75 | |||
| Virus Sargage (genotyping) | 42.50 | ||||
| Virus. | Sargareg IgG Virus (ELISA) |
13.75 | |||
|
Virus. | Sargareg IgM Virus (ELISA) | 27.75 |
|||
| Virus. | Tuscany Virus (actual PCR-time) | 106.00 | |||
| Virus. | IgG Tuscany Virus (ELISA) | 19.25 | |||
| IgM Tuscany Virus (ELISA) | 18.75 | ||||
| Virus. | Virus Varicela Zoster (FC) | 10.25 | |||
|
. | Virus Varicela Zoster IgG (ELISA) | 19.25 | |||
| Virus Varicela Zoster IgM (ELISA) | 15.00 |
||||
| Virus. | Virus West Nile (PCR-real-time) | 106.00 | |||
| West Nile Ac (neutralization) | 206.00 | ||||
| Virus. | Virus West Nile IgG (ELISA) | 21.00 |
|||
|
Virus. | Virus West Nile IgM (ELISA) | 44.00 |
